Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138540296> ?p ?o ?g. }
- W3138540296 abstract "In late 2019, the first cases of coronavirus disease 2019 (COVID-19) were reported in Wuhan, China, followed by a worldwide spread. Numerous countries have implemented control measures related to international travel, including border closures, travel restrictions, screening at borders, and quarantine of travellers.To assess the effectiveness of international travel-related control measures during the COVID-19 pandemic on infectious disease transmission and screening-related outcomes.We searched MEDLINE, Embase and COVID-19-specific databases, including the Cochrane COVID-19 Study Register and the WHO Global Database on COVID-19 Research to 13 November 2020.We considered experimental, quasi-experimental, observational and modelling studies assessing the effects of travel-related control measures affecting human travel across international borders during the COVID-19 pandemic. In the original review, we also considered evidence on severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). In this version we decided to focus on COVID-19 evidence only. Primary outcome categories were (i) cases avoided, (ii) cases detected, and (iii) a shift in epidemic development. Secondary outcomes were other infectious disease transmission outcomes, healthcare utilisation, resource requirements and adverse effects if identified in studies assessing at least one primary outcome.Two review authors independently screened titles and abstracts and subsequently full texts. For studies included in the analysis, one review author extracted data and appraised the study. At least one additional review author checked for correctness of data. To assess the risk of bias and quality of included studies, we used the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool for observational studies concerned with screening, and a bespoke tool for modelling studies. We synthesised findings narratively. One review author assessed the certainty of evidence with GRADE, and several review authors discussed these GRADE judgements.Overall, we included 62 unique studies in the analysis; 49 were modelling studies and 13 were observational studies. Studies covered a variety of settings and levels of community transmission. Most studies compared travel-related control measures against a counterfactual scenario in which the measure was not implemented. However, some modelling studies described additional comparator scenarios, such as different levels of stringency of the measures (including relaxation of restrictions), or a combination of measures. Concerns with the quality of modelling studies related to potentially inappropriate assumptions about the structure and input parameters, and an inadequate assessment of model uncertainty. Concerns with risk of bias in observational studies related to the selection of travellers and the reference test, and unclear reporting of certain methodological aspects. Below we outline the results for each intervention category by illustrating the findings from selected outcomes. Travel restrictions reducing or stopping cross-border travel (31 modelling studies) The studies assessed cases avoided and shift in epidemic development. We found very low-certainty evidence for a reduction in COVID-19 cases in the community (13 studies) and cases exported or imported (9 studies). Most studies reported positive effects, with effect sizes varying widely; only a few studies showed no effect. There was very low-certainty evidence that cross-border travel controls can slow the spread of COVID-19. Most studies predicted positive effects, however, results from individual studies varied from a delay of less than one day to a delay of 85 days; very few studies predicted no effect of the measure. Screening at borders (13 modelling studies; 13 observational studies) Screening measures covered symptom/exposure-based screening or test-based screening (commonly specifying polymerase chain reaction (PCR) testing), or both, before departure or upon or within a few days of arrival. Studies assessed cases avoided, shift in epidemic development and cases detected. Studies generally predicted or observed some benefit from screening at borders, however these varied widely. For symptom/exposure-based screening, one modelling study reported that global implementation of screening measures would reduce the number of cases exported per day from another country by 82% (95% confidence interval (CI) 72% to 95%) (moderate-certainty evidence). Four modelling studies predicted delays in epidemic development, although there was wide variation in the results between the studies (very low-certainty evidence). Four modelling studies predicted that the proportion of cases detected would range from 1% to 53% (very low-certainty evidence). Nine observational studies observed the detected proportion to range from 0% to 100% (very low-certainty evidence), although all but one study observed this proportion to be less than 54%. For test-based screening, one modelling study provided very low-certainty evidence for the number of cases avoided. It reported that testing travellers reduced imported or exported cases as well as secondary cases. Five observational studies observed that the proportion of cases detected varied from 58% to 90% (very low-certainty evidence). Quarantine (12 modelling studies) The studies assessed cases avoided, shift in epidemic development and cases detected. All studies suggested some benefit of quarantine, however the magnitude of the effect ranged from small to large across the different outcomes (very low- to low-certainty evidence). Three modelling studies predicted that the reduction in the number of cases in the community ranged from 450 to over 64,000 fewer cases (very low-certainty evidence). The variation in effect was possibly related to the duration of quarantine and compliance. Quarantine and screening at borders (7 modelling studies; 4 observational studies) The studies assessed shift in epidemic development and cases detected. Most studies predicted positive effects for the combined measures with varying magnitudes (very low- to low-certainty evidence). Four observational studies observed that the proportion of cases detected for quarantine and screening at borders ranged from 68% to 92% (low-certainty evidence). The variation may depend on how the measures were combined, including the length of the quarantine period and days when the test was conducted in quarantine.With much of the evidence derived from modelling studies, notably for travel restrictions reducing or stopping cross-border travel and quarantine of travellers, there is a lack of 'real-world' evidence. The certainty of the evidence for most travel-related control measures and outcomes is very low and the true effects are likely to be substantially different from those reported here. Broadly, travel restrictions may limit the spread of disease across national borders. Symptom/exposure-based screening measures at borders on their own are likely not effective; PCR testing at borders as a screening measure likely detects more cases than symptom/exposure-based screening at borders, although if performed only upon arrival this will likely also miss a meaningful proportion of cases. Quarantine, based on a sufficiently long quarantine period and high compliance is likely to largely avoid further transmission from travellers. Combining quarantine with PCR testing at borders will likely improve effectiveness. Many studies suggest that effects depend on factors, such as levels of community transmission, travel volumes and duration, other public health measures in place, and the exact specification and timing of the measure. Future research should be better reported, employ a range of designs beyond modelling and assess potential benefits and harms of the travel-related control measures from a societal perspective." @default.
- W3138540296 created "2021-03-29" @default.
- W3138540296 creator A5001757757 @default.
- W3138540296 creator A5003894233 @default.
- W3138540296 creator A5004958033 @default.
- W3138540296 creator A5006037634 @default.
- W3138540296 creator A5010850920 @default.
- W3138540296 creator A5013045255 @default.
- W3138540296 creator A5013411467 @default.
- W3138540296 creator A5014412723 @default.
- W3138540296 creator A5014748078 @default.
- W3138540296 creator A5015722679 @default.
- W3138540296 creator A5019412428 @default.
- W3138540296 creator A5025602085 @default.
- W3138540296 creator A5026042193 @default.
- W3138540296 creator A5029183004 @default.
- W3138540296 creator A5035211799 @default.
- W3138540296 creator A5040277421 @default.
- W3138540296 creator A5042100456 @default.
- W3138540296 creator A5056776883 @default.
- W3138540296 creator A5078625692 @default.
- W3138540296 creator A5085645932 @default.
- W3138540296 creator A5087509441 @default.
- W3138540296 creator A5090137933 @default.
- W3138540296 date "2021-03-25" @default.
- W3138540296 modified "2023-10-01" @default.
- W3138540296 title "International travel-related control measures to contain the COVID-19 pandemic: a rapid review" @default.
- W3138540296 cites W1573140501 @default.
- W3138540296 cites W1601435989 @default.
- W3138540296 cites W1976768055 @default.
- W3138540296 cites W1994158325 @default.
- W3138540296 cites W2006560005 @default.
- W3138540296 cites W2010364678 @default.
- W3138540296 cites W2040491084 @default.
- W3138540296 cites W2044696281 @default.
- W3138540296 cites W2048512240 @default.
- W3138540296 cites W2050910323 @default.
- W3138540296 cites W2051156467 @default.
- W3138540296 cites W2060513754 @default.
- W3138540296 cites W2067354408 @default.
- W3138540296 cites W2080259582 @default.
- W3138540296 cites W2081028562 @default.
- W3138540296 cites W2096791630 @default.
- W3138540296 cites W2100776472 @default.
- W3138540296 cites W2107638293 @default.
- W3138540296 cites W2119388781 @default.
- W3138540296 cites W2122208012 @default.
- W3138540296 cites W2140522719 @default.
- W3138540296 cites W2141663349 @default.
- W3138540296 cites W2142814545 @default.
- W3138540296 cites W2147476848 @default.
- W3138540296 cites W2156098321 @default.
- W3138540296 cites W2156989562 @default.
- W3138540296 cites W2158127593 @default.
- W3138540296 cites W2171153895 @default.
- W3138540296 cites W2234882386 @default.
- W3138540296 cites W2355430189 @default.
- W3138540296 cites W246286872 @default.
- W3138540296 cites W2520606239 @default.
- W3138540296 cites W2531269403 @default.
- W3138540296 cites W2560438049 @default.
- W3138540296 cites W2616456691 @default.
- W3138540296 cites W2645531277 @default.
- W3138540296 cites W2751008446 @default.
- W3138540296 cites W2767452807 @default.
- W3138540296 cites W2792308249 @default.
- W3138540296 cites W2899959647 @default.
- W3138540296 cites W2936961514 @default.
- W3138540296 cites W2963685768 @default.
- W3138540296 cites W2974747689 @default.
- W3138540296 cites W2990648940 @default.
- W3138540296 cites W2991173197 @default.
- W3138540296 cites W3004641139 @default.
- W3138540296 cites W3004887441 @default.
- W3138540296 cites W3005024352 @default.
- W3138540296 cites W3005151538 @default.
- W3138540296 cites W3006750069 @default.
- W3138540296 cites W3007262359 @default.
- W3138540296 cites W3007443927 @default.
- W3138540296 cites W3007944779 @default.
- W3138540296 cites W3008028633 @default.
- W3138540296 cites W3008049045 @default.
- W3138540296 cites W3010077538 @default.
- W3138540296 cites W3010131837 @default.
- W3138540296 cites W3010619285 @default.
- W3138540296 cites W3010655137 @default.
- W3138540296 cites W3011454564 @default.
- W3138540296 cites W3011667203 @default.
- W3138540296 cites W3011999140 @default.
- W3138540296 cites W3012188173 @default.
- W3138540296 cites W3012353305 @default.
- W3138540296 cites W3012922240 @default.
- W3138540296 cites W3013594674 @default.
- W3138540296 cites W3015061143 @default.
- W3138540296 cites W3015062758 @default.
- W3138540296 cites W3015185421 @default.
- W3138540296 cites W3015203085 @default.
- W3138540296 cites W3015655164 @default.
- W3138540296 cites W3016130172 @default.
- W3138540296 cites W3016702327 @default.